Recent studies have demonstrated that passive immunization of neonatal rats to GRF inhibited their somatic growth through the suppression of GH secretion, In this study, we investigated the changes in pituitary GRF receptor (GRFR) expression in GRF antibody (GRF-ab) treated rats. Neonatal rats were treated from day 1 today 10 after birth with every other day sc injection of 50 mu l of normal rabbit serum (groups I: control & III) or rabbit serum containing GRF-ab (groups II & IV). In addition, groups III & IV received twice daily injection of recombinant human GH (0.4 mu g/kg, sc). The rats were sacrificed on day 11 and pituitaries were removed. The pituitary weights in all treatment groups were decreased compared to the control group (I). Total pituitary RNA was extracted and GRFR mRNA levels were determined by RNase protection assay. Receptor RNA levels were quantitated and normalized to an internal standard, glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The ratios of GRFR mRNA to GAPDH mRNA were significantly decreased to 49.6 +/- 4.9 (mean +/- SD), 73.0 +/- 8.7, 43.6 +/- 9.5% of control group I in the experimental groups II, III, and IV, respectively (P<0.01). These data suggest that (1) suppression of GH secretion in GRF-ab heated animals was due, at least in pari, to a decrease in GRFR expression, (2) GRF may be necessary for ifs own receptor expression, (3) exogenous administration of GH suppresses pituitary GRFR mRNA.

Growth hormone-releasing factor (GRF) regulates expression of its own receptors / R. Horikawa, P. Hellmann, S. Cella, A. Torsello, R. Day, E. Müller, M. Thorner. - In: ENDOCRINOLOGY. - ISSN 0013-7227. - 137:6(1996), pp. 2642-2645.

Growth hormone-releasing factor (GRF) regulates expression of its own receptors

S. Cella;
1996

Abstract

Recent studies have demonstrated that passive immunization of neonatal rats to GRF inhibited their somatic growth through the suppression of GH secretion, In this study, we investigated the changes in pituitary GRF receptor (GRFR) expression in GRF antibody (GRF-ab) treated rats. Neonatal rats were treated from day 1 today 10 after birth with every other day sc injection of 50 mu l of normal rabbit serum (groups I: control & III) or rabbit serum containing GRF-ab (groups II & IV). In addition, groups III & IV received twice daily injection of recombinant human GH (0.4 mu g/kg, sc). The rats were sacrificed on day 11 and pituitaries were removed. The pituitary weights in all treatment groups were decreased compared to the control group (I). Total pituitary RNA was extracted and GRFR mRNA levels were determined by RNase protection assay. Receptor RNA levels were quantitated and normalized to an internal standard, glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The ratios of GRFR mRNA to GAPDH mRNA were significantly decreased to 49.6 +/- 4.9 (mean +/- SD), 73.0 +/- 8.7, 43.6 +/- 9.5% of control group I in the experimental groups II, III, and IV, respectively (P<0.01). These data suggest that (1) suppression of GH secretion in GRF-ab heated animals was due, at least in pari, to a decrease in GRFR expression, (2) GRF may be necessary for ifs own receptor expression, (3) exogenous administration of GH suppresses pituitary GRFR mRNA.
passive-immunization; molecular-cloning; somatic growth; rats; deprivation; antibodies; secretion
Settore BIO/14 - Farmacologia
1996
Article (author)
File in questo prodotto:
File Dimensione Formato  
endo2642.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 790.78 kB
Formato Adobe PDF
790.78 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/453627
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 42
social impact